AZD2461
AZD2461 is a novel PARP inhibitor with low affinity for than Olaparib. AZD2641 is currently in Phase I clinical studies to treat solid tumors.
Product Specifications
Background
Unlike treatment with AZD 2281 (Olaparib, Axon 1464), AZD 2461 succesfully circumvents drug resistance of Pgp-proficient tumors, and inactivation of p53-binding protein 1 (53BP1) as a causal factor in PARPi resistance.
CAS Number
1174043-16-3
Purity
≥ 98% by HPLC
Solubility
Soluble in DMSO
Molecular Formula
C22H22FN3O3
Shipping Conditions
Room Temperature (continental US) or Gel Packs
Storage Conditions
Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Calculated Molecular Weight
395.4 Da
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
364673 200 µL
PLA2G2D (Phospholipase A2, Group IID, PLA2G2D, sPLA2S, s-PLA2, sPLA2, SPLASH, Secreted Phospholipase A2, Phosphatidylcholine 2-acylhydrolase 2D, Secretory-type PLA, stroma-associated homolog)
Ask
View Details 
GTR15330424 1 Vial
Lentiviral human GPR50 shRNA (UAS) - Lentiviral human GPR50 shRNA (UAS, RFP) plasmid
Ask
View Details 
MBS1242317-01 0.02 mg (E-Coli)
Recombinant Arabidopsis thaliana Cyclin-U4-1 (CYCU4-1)
Ask
View Details 
MBS1242317-02 0.1 mg (E-Coli)
Recombinant Arabidopsis thaliana Cyclin-U4-1 (CYCU4-1)
Ask
View Details MBS1242317-03 0.02 mg (Yeast)
Recombinant Arabidopsis thaliana Cyclin-U4-1 (CYCU4-1)
Ask
View Details MBS1242317-04 0.1 mg (Yeast)
Recombinant Arabidopsis thaliana Cyclin-U4-1 (CYCU4-1)
Ask
View Details